Literature DB >> 27408339

Prevalence of netF-positive Clostridium perfringens in foals in southwestern Ontario.

Abigail Finley1, Iman Mehdizadeh Gohari1, Valeria R Parreira1, Miranda Abrahams1, Henry R Staempfli1, John F Prescott1.   

Abstract

NetF-producing Clostridium perfringens have recently been identified as a cause of necrotizing enteritis in neonatal foals, but little is known about its prevalence in clinically normal foals. Foals (n = 88) ranging in age from < 1 wk to 2 to 4 mo (median age 2 to 4 wk) on 8 horse-breeding farms in Ontario were examined on 1 or 2 occasions for the presence of C. perfringens. Of the foals that tested positive, 5 isolates (n = 675) were examined for the netF and enterotoxin (cpe) genes. Colonization by C. perfringens was most marked in foals < 1 wk of age [4.85 ± 2.70 log10 colony-forming units (CFU)] and declined markedly over time (1.23 ± 1.06 log10 CFU at 1 to 2 mo of age). Only 2 isolates possessed the cpe gene and none possessed netF. We concluded that netF-positive C. perfringens does not colonize young foals with any detectable frequency in Ontario and this organism is not likely to be adapted to the intestine of the horse.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27408339      PMCID: PMC4924560     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  13 in total

1.  Population-based study of fecal shedding of Clostridium perfringens in broodmares and foals.

Authors:  Kirsten Tillotson; Josie L Traub-Dargatz; Charles E Dickinson; Robert P Ellis; Paul S Morley; Doreene R Hyatt; Roberta J Magnuson; W Thomas Riddle; Denise Bolte; M D Salman
Journal:  J Am Vet Med Assoc       Date:  2002-02-01       Impact factor: 1.936

2.  Foaling-management practices associated with the occurrence of enterocolitis attributed to Clostridium perfringens infection in the equine neonate.

Authors:  L M East; D A Dargatz; J L Traub-Dargatz; C J Savage
Journal:  Prev Vet Med       Date:  2000-07-03       Impact factor: 2.670

3.  The Clostridium perfringens enterotoxin from equine isolates; its characterization, sequence and role in foal diarrhoea.

Authors:  T Netherwood; M Binns; H Townsend; J L Wood; J A Mumford; N Chanter
Journal:  Epidemiol Infect       Date:  1998-03       Impact factor: 2.451

4.  The development of the flora of the alimentary tract in young animals.

Authors:  H W Smith
Journal:  J Pathol Bacteriol       Date:  1965-10

5.  Characterization of Clostridium perfringens in the feces of adult horses and foals with acute enterocolitis.

Authors:  Iman Mehdizadeh Gohari; Luis Arroyo; Janet I Macinnes; John F Timoney; Valeria R Parreira; John F Prescott
Journal:  Can J Vet Res       Date:  2014-01       Impact factor: 1.310

6.  Detection of A/B toxin and isolation of Clostridium difficile and Clostridium perfringens from foals.

Authors:  R O S Silva; M G Ribeiro; M S Palhares; A S Borges; R P A Maranhão; M X Silva; T M Lucas; G Olivo; F C F Lobato
Journal:  Equine Vet J       Date:  2013-03-03       Impact factor: 2.888

7.  Enterocolitis associated with Clostridium perfringens infection in neonatal foals: 54 cases (1988-1997).

Authors:  L M East; C J Savage; J L Traub-Dargatz; C E Dickinson; R P Ellis
Journal:  J Am Vet Med Assoc       Date:  1998-06-01       Impact factor: 1.936

8.  A novel pore-forming toxin in type A Clostridium perfringens is associated with both fatal canine hemorrhagic gastroenteritis and fatal foal necrotizing enterocolitis.

Authors:  Iman Mehdizadeh Gohari; Valeria R Parreira; Victoria J Nowell; Vivian M Nicholson; Kaitlyn Oliphant; John F Prescott
Journal:  PLoS One       Date:  2015-04-08       Impact factor: 3.240

9.  The epidemiology of Clostridium perfringens type A on Ontario swine farms, with special reference to cpb2-positive isolates.

Authors:  Gloria Chan; Abdolvahab Farzan; Glenn Soltes; Vivian M Nicholson; Yanlong Pei; Robert Friendship; John F Prescott
Journal:  BMC Vet Res       Date:  2012-09-04       Impact factor: 2.741

10.  Infectious agents detected in the feces of diarrheic foals: a retrospective study of 233 cases (2003-2008).

Authors:  J Frederick; S Giguère; L C Sanchez
Journal:  J Vet Intern Med       Date:  2009-09-11       Impact factor: 3.333

View more
  6 in total

Review 1.  Comparative pathogenesis of enteric clostridial infections in humans and animals.

Authors:  Francisco A Uzal; Mauricio A Navarro; Jihong Li; John C Freedman; Archana Shrestha; Bruce A McClane
Journal:  Anaerobe       Date:  2018-06-05       Impact factor: 3.331

2.  Fecal PCR testing for detection of Clostridium perfringens and Clostridioides difficile toxin genes and other pathogens in foals with diarrhea: 28 cases.

Authors:  K Gary Magdesian; Samantha Barnum; Nicola Pusterla
Journal:  J Vet Diagn Invest       Date:  2021-09-23       Impact factor: 1.569

Review 3.  Bacterial and viral enterocolitis in horses: a review.

Authors:  Francisco A Uzal; Luis G Arroyo; Mauricio A Navarro; Diego E Gomez; Javier Asín; Eileen Henderson
Journal:  J Vet Diagn Invest       Date:  2021-11-11       Impact factor: 1.569

Review 4.  NetF-producing Clostridium perfringens and its associated diseases in dogs and foals.

Authors:  Iman Mehdizadeh Gohari; Stefan Unterer; Ashley E Whitehead; John F Prescott
Journal:  J Vet Diagn Invest       Date:  2020-02-21       Impact factor: 1.279

Review 5.  Expansion of the Clostridium perfringens toxin-based typing scheme.

Authors:  Julian I Rood; Vicki Adams; Jake Lacey; Dena Lyras; Bruce A McClane; Stephen B Melville; Robert J Moore; Michel R Popoff; Mahfuzur R Sarker; J Glenn Songer; Francisco A Uzal; Filip Van Immerseel
Journal:  Anaerobe       Date:  2018-04-20       Impact factor: 3.331

6.  Prevalence of Clostridium perfringens netE and netF toxin genes in the feces of dogs with acute hemorrhagic diarrhea syndrome.

Authors:  Natalie Sindern; Jan S Suchodolski; Christian M Leutenegger; Iman Mehdizadeh Gohari; John F Prescott; Anna-Lena Proksch; Ralf S Mueller; Kathrin Busch; Stefan Unterer
Journal:  J Vet Intern Med       Date:  2018-11-30       Impact factor: 3.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.